Bioactive Compounds
-
C8761 Eflornithine hydrochlorideSummary: An irreversible ornithine decarboxylase (ODC) inhibitor -
C8762 TomivosertibSummary: A potent, highly selective, orally active MNK1 and MNK2 inhibitor -
C8763 AUNP-12Summary: A novel immune checkpoint modulator, a competitive antagonist targeting the PD-1/PD-L1 pathway. -
C8764 CGRP 8-37 (rat) acetateSummary: A CGRP receptor antagonist -
C8765 TAS-102Summary: An oral nucleoside antitumor combination consisting of Trifluridine and Tipiracil -
A9949 Epinecidin-1Summary: An antimicrobial peptide -
BA7012 ResiniferatoxinSummary: A selective TRPV1 receptor agonist isolated from Euphorbia resinifera that eliminates TRPV1+ sensory neurons for pain -
BA7745 α-Glucosidase, YeastSummary: Yeast α-glucosidase (maltase; EC 3.2.1.20) releases glucose from α-glucosides and is used in carbohydrate hydrolysis and enzyme-inhibition studies. -
BA8213 YonkenafilSummary: Yonkenafil (Tunodafil) is a novel phosphodiesterase 5 inhibitor that is effective in reducing cerebral infarction, neurological deficits, edema, and neuronal damage in the infarcted area. -
BA4816 ValemetostatSummary: A first-in-class EZH1/2 dual inhibitor for relapsed or refractory peripheral T-cell lymphoma

